Profil
Carolyn McAuliffe is currently working as a Senior Director-Communications at Aerie Pharmaceuticals, Inc. since 2021.
Prior to this, she worked as Head-Communications at Masimo Corp.
Aktive Positionen von Carolyn McAuliffe
| Unternehmen | Position | Beginn |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Public Communications Contact | 13.09.2021 |
Ehemalige bekannte Positionen von Carolyn McAuliffe
| Unternehmen | Position | Ende |
|---|---|---|
| MASIMO CORPORATION | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MASIMO CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
